PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 223 filers reported holding PDL BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is 2.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $106,000 | -32.1% | 29,905 | -3.8% | 0.02% | -34.8% |
| Q3 2015 | $156,000 | -31.0% | 31,102 | -11.6% | 0.02% | -37.8% |
| Q2 2015 | $226,000 | -5.0% | 35,185 | +4.2% | 0.04% | -5.1% |
| Q1 2015 | $238,000 | -7.8% | 33,782 | +0.6% | 0.04% | -7.1% |
| Q4 2014 | $258,000 | -9.5% | 33,586 | -12.1% | 0.04% | -16.0% |
| Q3 2014 | $285,000 | -20.2% | 38,198 | +3.5% | 0.05% | -26.5% |
| Q2 2014 | $357,000 | +16.7% | 36,919 | +0.2% | 0.07% | +11.5% |
| Q1 2014 | $306,000 | -89.1% | 36,853 | -42.9% | 0.06% | -41.3% |
| Q4 2013 | $2,803,000 | +990.7% | 64,528 | +100.0% | 0.10% | +85.7% |
| Q3 2013 | $257,000 | +6.6% | 32,264 | +3.3% | 0.06% | -3.4% |
| Q2 2013 | $241,000 | – | 31,222 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KESTREL INVESTMENT MANAGEMENT CORP | 1,465,000 | $3,853,000 | 1.56% |
| SMH CAPITAL ADVISORS INC | 93,708 | $246,000 | 0.42% |
| West Family Investments, Inc. | 627,800 | $1,651,000 | 0.39% |
| KENNEDY CAPITAL MANAGEMENT LLC | 7,082,858 | $18,628,000 | 0.35% |
| ARMISTICE CAPITAL, LLC | 1,800,000 | $4,734,000 | 0.28% |
| BRANDES INVESTMENT PARTNERS, LP | 3,936,719 | $10,354,000 | 0.23% |
| ROCKY MOUNTAIN ADVISERS, LLC | 14,300 | $38,000 | 0.13% |
| Zebra Capital Management LLC | 74,695 | $196,000 | 0.09% |
| Connor, Clark & Lunn Investment Management Ltd. | 5,968,105 | $15,696,000 | 0.09% |
| CREDIT AGRICOLE S A | 471,644 | $1,240,000 | 0.06% |